🔥Telegram İfşa

Impossible to put a number on the patients who benefitted from DR Endo's research. It changed everything in Therapeutic Lipidology. I practiced IM in the dark ages (e.g. no practically useable lipid Rx) for 15 years (1972-1987) prior to statin availability - soon after statins

This is such sad news and it is a shame The Nobel Committee never honored him. His work has reduced more CV morbidity and mortality that virtually any other

Lipidaholics: Here is some good learning material for clinical lipidologists or those aspiring to be one: Think you understand cellular CHOLESTEROL HOMEOSTASIS? If so, then you will not only know what every single thing in my graphic is but explain in detail the function and

Today is World Heart Day! At ISCP, we are committed to promoting cardiovascular health across the globe by advancing research and education . ❤️

Excited to join #ISCP2024 in São Paulo! I’ll cover 2 key topics: what to do when statins aren’t enough + NOACs & emerging agents, Join us Nov 1-2! 📍 Hotel Renaissance, São Paulo 👉 Register now: buff.ly/3ZVZJDT #Cardiology #HeartHealth Toni Martinez Rubio Alberto J. Lorenzatti, MD, MTFAC, FACC

Oral Semaglutide demonstrates 14% in MACE in adults with T2DM in the SOUL trial. Great achievement!! I’m proud to have been part of this pivotal study!!!👇🏻

🚀 Unlock the future of #CardiovascularCare! Learn how personalized medicine is reshaping treatments for heart disease and more. Check out insights from our Romanian ISCP symposium! 💡 #Cardiology #ISCP Discover more:buff.ly/4dWwtQI